Keyphrases
Interleukin-12 (IL-12)
100%
Local Delivery
100%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
100%
Vascular Tumor
100%
T Cell Targeting
100%
T Cells
77%
Chimeric Antigen Receptor T Cells (CAR-T)
66%
Anti-vascular Endothelial Growth Factor (anti-VEGF)
44%
Tumor
33%
Tumor Regression
22%
Syngeneic
22%
Tumor Environment
22%
Solid Tumors
11%
Histology
11%
Interleukin-2
11%
Inflammatory Cytokines
11%
Adoptive Transfer
11%
Genetic Engineering
11%
Tumor Subtype
11%
Tumor Growth
11%
B Cells
11%
CD11b+
11%
Antitumor Effect
11%
Lymphodepletion
11%
Targeted Delivery
11%
Subcutaneous Tumor
11%
Interleukin
11%
Cell Subsets
11%
Myeloid-derived Suppressor Cells
11%
Anti-VEGFR
11%
Immunosuppressive Tumor
11%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Mouse
100%
Interleukin 12
100%
Vasculotropin Receptor 2
100%
Chimeric Antigen Receptor
66%
Cytokine
22%
Tumor Regression
22%
Blood Group A Antigen
22%
Solid Malignant Neoplasm
11%
Interleukin 2
11%
Tumor Growth
11%
Immunosuppressive Agent
11%
Murine
11%
Immunology and Microbiology
T Cell
100%
Mouse
100%
Interleukin 12
100%
Kinase Insert Domain Receptor
100%
Chimeric Antigen Receptor
66%
Syngenic
22%
Cytokine
11%
Interleukin 2
11%
B Cell
11%
Proinflammatory Cytokine
11%
Murine
11%
Immunosuppressive Drug
11%
Interleukin
11%
Myeloid Suppressor Cell
11%
Engineering
Myeloid Suppressor Cell
12%